Skip to content

Scientific Advisory Committee

Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Former Members

  • Jeff Boyd, PhD
  • Carmel J. Cohen, MD
  • Alan D. D’Andrea, MD
  • Ronny I. Drapkin, MD, PhD
  • Annie Ellis
  • Ellen L. Goode, PhD
  • Susan Leighton
  • Ernst Lengyel, MD, PhD
  • Douglas A. Levine, MD
  • Joyce Liu, MD
  • Carolyn Muller, MD, FACOG
  • Kunle Odunsi, MD, PhD
  • Bob Ozols, MD, PhD
  • Daniel J. Powell Jr., PhD
  • Stephen C. Rubin, MD
  • Michael Seiden, MD, PhD
  • Elizabeth Swisher, MD

Related Topics

The Overview: February 2026

The Overview: February 2026

The Global Ovarian Cancer Research Consortium awarded its inaugural AI Accelerator Grant in February—and the announcement has been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients. The $1 million global research grant, plus an additional $1 million in compute support from Microsoft’s AI for … Continued

Read more

Ovarian Cancer Research Alliance Honors Researchers with 2025 Rosalind Franklin and Schreiber Prizes

Ovarian Cancer Research Alliance Honors Researchers with 2025 Rosalind Franklin and Schreiber Prizes

Recognizing Advances in Ovarian Cancer Research and Immunotherapy Ovarian Cancer Research Alliance (OCRA) announced today the winners of two prizes recognizing exceptional accomplishments in ovarian cancer research.  David Huntsman, MD, FRCPC, FCCMG, was awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research for his findings that have profoundly impacted the treatment of … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.